These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Ocular side effects through oral contraceptives (author's transl)]. Rochels R; Nover A Geburtshilfe Frauenheilkd; 1980 Aug; 40(8):713-5. PubMed ID: 7409430 [TBL] [Abstract][Full Text] [Related]
24. [Flupirtine in acute and chronic pain associated with muscle tenseness. Results of a postmarket surveillance study]. Mueller-Schwefe G Fortschr Med Orig; 2003; 121(1):11-8. PubMed ID: 15117064 [TBL] [Abstract][Full Text] [Related]
25. Ocular safety of Viagra, (sildenafil citrate). Laties AM; Fraunfelder FT Trans Am Ophthalmol Soc; 1999; 97():115-25; discussion 125-8. PubMed ID: 10703120 [TBL] [Abstract][Full Text] [Related]
26. Dose-proportional plasma levels of the analgesic flupirtine maleate in man. Application of a new HPLC assay. Niebch G; Borbe HO; Hummel T; Kobal G Arzneimittelforschung; 1992 Nov; 42(11):1343-5. PubMed ID: 1492848 [TBL] [Abstract][Full Text] [Related]
27. [Clinical trial of a novel benzodiazepine derivative in a double-blind study using the Wittenborn psychiatric rating scale (author's transl)]. Husser J; Seffen J; Wolf GK Arzneimittelforschung; 1975 Oct; 25(10):1650. PubMed ID: 1043 [TBL] [Abstract][Full Text] [Related]
28. [Clinical trial of tramadol by means of the "paired card" system (author's transl)]. Schenck EG; Arend I Arzneimittelforschung; 1978; 28(1a):196-9. PubMed ID: 343788 [TBL] [Abstract][Full Text] [Related]
29. [Comparative double-blind study of the analgesic activity of fosfosal (UR-1521) in patients with musculoskeletal and articular pain (author's transl)]. Madera Cat L; García Rafanell JM Med Clin (Barc); 1981 Jan; 76(1):18-22. PubMed ID: 7012470 [TBL] [Abstract][Full Text] [Related]
30. [Examination of psychic effects of a new analgesic agent of the cyclohexanols series. A contribution to a possible psychic dependence potential of tramadol (author's transl)]. Huber HP Arzneimittelforschung; 1978; 28(1a):189-91. PubMed ID: 580217 [TBL] [Abstract][Full Text] [Related]
31. The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol. Inan UU; Ermis SS; Orman A; Onrat E; Yucel A; Ozturk F; Asagidag A; Celik A J Ocul Pharmacol Ther; 2004 Aug; 20(4):293-310. PubMed ID: 15321024 [TBL] [Abstract][Full Text] [Related]
32. Safety and tolerability of naproxen ophthalmic solution in comparison to placebo. Papa V; Waitzinger J; Pabst G; Milazzo G; Müller M; Marrano M; Santocono M; Roth HW Int J Clin Pharmacol Ther; 1999 Mar; 37(3):133-40. PubMed ID: 10190761 [TBL] [Abstract][Full Text] [Related]
33. Abuse potential and physical dependence liability studies with flupirtine maleate in laboratory animals. Sofia RD; Diamantis W; Gordon R Postgrad Med J; 1987; 63 Suppl 3():35-40. PubMed ID: 3447127 [TBL] [Abstract][Full Text] [Related]
34. Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential. Nickel B; Borbe HO; Szelenyi I Arzneimittelforschung; 1990 Aug; 40(8):905-8. PubMed ID: 1978681 [TBL] [Abstract][Full Text] [Related]
35. Norepinephrine dipivalylate dose-response in ocular hypertensive subjects. Stewart RH; Kimbrough RL; Martin PA; Ward RL; Smith JP Ann Ophthalmol; 1981 Nov; 13(11):1279-83. PubMed ID: 7034617 [TBL] [Abstract][Full Text] [Related]
36. The analgesic efficacy of flupirtine in comparison to pentazocine and placebo assessed by EEG and subjective pain ratings. Bromm B; Ganzel R; Herrmann WM; Meier W; Scharein E Postgrad Med J; 1987; 63 Suppl 3():109-12. PubMed ID: 2451815 [TBL] [Abstract][Full Text] [Related]
38. Green urine following exposure to flupirtine. Maier A; Liu Y; Scholze A; Westhoff TH; Tepel M Am J Kidney Dis; 2010 Nov; 56(5):1014-5. PubMed ID: 20970027 [No Abstract] [Full Text] [Related]
39. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
40. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia. Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]